First trial of the HIV-1 vaccine in Africa: Ugandan experience

This publication has 10 references indexed in Scilit:

• Developing AIDS Vaccine Trials Educational Programs in Uganda
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
• Human immunodeficiency virus vaccine development in developing countries: are efficacy trials feasible?
  2000
• Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?
  The Lancet, 2000
• Safety and Immunogenicity of a Live Recombinant Canarypox Virus Expressing HIV Type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) Followed by a p24E-V3 MN Synthetic Peptide (CLTB-36) Administered in Healthy Volunteers at Low Risk for HIV Infection
  AIDS Research and Human Retroviruses, 1999
• HIV vaccine development for the world: an idea whose time has come?
  1998
• Bioethics and Local Circumstances
  Science, 1998
• HIV-1 Risk and Vaccine Acceptability in the Ugandan Military
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
• The safety and use of canarypox vectored vaccines.
  1995
• Ethical, Behavioral, and Social Aspects of HIV Vaccine Trials in Developing Countries
  JAMA, 1994
• Behavioral research contributions to planning and conducting HIV vaccine efficacy studies.
  1994